Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • shocker8786
    Member
    • Jan 2013
    • 28

    GATK IndelRealigner error

    Hello,

    I'm attempting to use GATK 2.3-9-ge5ebf34 to re-align some RNA-seq datasets. Below is the code I'm using.

    java -Xms16g -jar ~/bin/GenomeAnalysisTK-2.3-9-ge5ebf34/GenomeAnalysisTK.jar -T IndelRealigner -R ../../../transcripts/reference_wMT.fa -I fat_no_dup.bam -targetIntervals fat_no_dup.intervals -o fat_nd_realigned.bam

    I'm receiving 2 errors that occur at many locations in the output. The first is below:

    IndelRealigner - When first element of the alt consensus is M, the second one must be I or D. Actual: 85M208M2D15M.

    I see that the issue is there are 2 M fields when it is only expecting 1. But I'm unsure of what this means, or what I can do to fix it. The bam file was aligned using tophat and allowing only 1 alignment per read. Any thoughts?

    The second error is:

    IndelRealigner - Not attempting realignment in interval 12:26475533-26475760 because there are too many reads.

    I know the issue here is there are too many reads at that interval, so I have to increase the -maxReadsForRealignment setting. Does anyone know of a way to determine what the highest coverage is for one of these regions, so I can set the max reads above that level, instead of picking a random number and trying again? Thanks!
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    In the first instance, the CIGAR string makes no sense. It should be 293M2D15M. For the second warning (these aren't errors), that's just an informative message to tell you that the coverage in that region is too high. There's no reason to play with -maxReadforRealignment too much, since those regions should just be ignored anyway.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM
    • SEQadmin2
      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
      by SEQadmin2



      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
      ...
      07-09-2026, 11:10 AM
    • SEQadmin2
      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
      by SEQadmin2



      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
      07-08-2026, 05:17 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 07-20-2026, 11:10 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-13-2026, 10:26 AM
    0 responses
    32 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-09-2026, 10:04 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-08-2026, 10:08 AM
    0 responses
    29 views
    0 reactions
    Last Post SEQadmin2  
    Working...